以前的研究工作已經(jīng)識(shí)別出，由組蛋白乙?；斐傻娜旧|(zhì)修飾是學(xué)習(xí)和記憶過程的一個(gè)促動(dòng)因素,，研究方法是,，對(duì)嚙齒類模型施用組蛋白脫乙酰酶（HDAC）抑制因子,。
現(xiàn)在,，用小鼠進(jìn)行的實(shí)驗(yàn)表明，是HDAC2,、而不是HDAC1的神經(jīng)元水平與突觸可塑性,、記憶形成及跟記憶相關(guān)的樹狀結(jié)構(gòu)變化的誘導(dǎo)成逆相關(guān)。另外,，HDAC2專門與被認(rèn)為在彈性和記憶中所涉及的基因相關(guān)聯(lián),，而HDAC1則不。這些發(fā)現(xiàn)提出一個(gè)可能性：以HDAC2（而不是HDAC1）為目標(biāo)的藥物在與記憶喪失相關(guān)的人類疾病的治療中也許會(huì)有價(jià)值,。（生物谷Bioon.com）
生物谷推薦原始出處：
Nature 459, 55-60 (7 May 2009) | doi:10.1038/nature07925
HDAC2 negatively regulates memory formation and synaptic plasticity
Ji-Song Guan1,2,3,9, Stephen J. Haggarty3,4,9, Emanuela Giacometti5,6,9, Jan-Hermen Dannenberg7,9,10, Nadine Joseph1,2,3, Jun Gao1,2, Thomas J. F. Nieland3, Ying Zhou1,2, Xinyu Wang1,2, Ralph Mazitschek3,8, James E. Bradner3, Ronald A. DePinho7, Rudolf Jaenisch5,6 & Li-Huei Tsai1,2,3
1 Picower Institute for Learning and Memory, Department of Brain and Cognitive Sciences,
2 Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
3 Stanley Center for Psychiatric Research, Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, Massachusetts 02142, USA
4 Center for Human Genetic Research, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02142, USA
5 Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142, USA
6 Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
7 Belfer Institute for Applied Cancer Science, Departments of Medical Oncology, Medicine and Genetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA
8 Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 240 Longwood Avenue, Boston, Massachusetts 02115, USA
9 These authors contributed equally to this work.
Chromatin modifications, especially histone-tail acetylation, have been implicated in memory formation. Increased histone-tail acetylation induced by inhibitors of histone deacetylases (HDACis) facilitates learning and memory in wild-type mice as well as in mouse models of neurodegeneration. Harnessing the therapeutic potential of HDACis requires knowledge of the specific HDAC family member(s) linked to cognitive enhancement. Here we show that neuron-specific overexpression of HDAC2, but not that of HDAC1, decreased dendritic spine density, synapse number, synaptic plasticity and memory formation. Conversely, Hdac2 deficiency resulted in increased synapse number and memory facilitation, similar to chronic treatment with HDACis in mice. Notably, reduced synapse number and learning impairment of HDAC2-overexpressing mice were ameliorated by chronic treatment with HDACis. Correspondingly, treatment with HDACis failed to further facilitate memory formation in Hdac2-deficient mice. Furthermore, analysis of promoter occupancy revealed an association of HDAC2 with the promoters of genes implicated in synaptic plasticity and memory formation. Taken together, our results suggest that HDAC2 functions in modulating synaptic plasticity and long-lasting changes of neural circuits, which in turn negatively regulates learning and memory. These observations encourage the development and testing of HDAC2-selective inhibitors for human diseases associated with memory impairment.
